Those companies are building their tests on our platform and bringing them to market beginning later this year. So we are just continuing to support our partners as they move their products to market. Today, we have about 27 partners in all areas of the life science industry. We could have 50 or more partners in the next couple of years that address every need of the life science industry. So we will be able to grow both with our partners and internally with our own sales force which has already placed instruments all over the world.
People don t stop going to the doctor during a recession.
Food safety will remain a concern in a recession. There are probably some aspects of biological testing that could be impacted by the economy, but we re involved in so many areas of this market that we don t expect to notice any significant impact. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.